tiprankstipranks
Irwin Naturals Inc (TSE:IWIN)
CNQX:IWIN
Holding TSE:IWIN?
Track your performance easily

Irwin Naturals Inc (IWIN) Income Statement

2 Followers

Irwin Naturals Inc Income Statement

Last quarter (Q3 2023), Irwin Naturals Inc's total revenue was $19.07M, a decrease of -71.29% from the same quarter last year. In Q3, Irwin Naturals Inc's net income was $-1.74M. See Irwin Naturals Inc’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Dec 22Dec 21Dec 20
Total Revenue
$ 86.75M$ 89.47M$ 100.34M$ 89.38M
Cost of Revenue
$ 48.42M$ 48.73M$ 55.65M$ 52.88M
Gross Profit
$ 38.33M$ 40.74M$ 44.69M$ 36.50M
Operating Expense
$ 46.46M$ 39.40M$ 34.12M$ 28.90M
Operating Income
$ -8.33M$ 1.34M$ 10.57M$ 7.61M
Net Non Operating Interest Income Expense
$ -1.70M$ -767.00K$ 131.00K$ -302.00K
Other Income Expense
$ 12.90M$ 1.54M$ -2.51M$ 53.00K
Pretax Income
$ -19.93M$ -970.00K$ 7.93M$ 7.36M
Tax Provision
$ -4.70M$ 1.55M$ -2.19M$ 116.00K
Earnings From Equity Interest Net Of Tax
----
Net Income Common Stockholders
$ -19.34M$ -3.99M$ 8.62M$ 7.24M
Basic EPS
$ -4.40$ -2.79$ 8.43$ 6.03
Diluted EPS
$ -4.40$ -2.79$ 0.03$ 6.03
Basic Average Shares
$ 8.12M$ 1.43M$ 1.20M$ 1.20M
Diluted Average Shares
$ 8.12M$ 1.43M$ 312.22M$ 1.20M
Dividend Per Share
----
Total Operating Income As Reported
----
Reported Normalized Basic E P S
----
Reported Normalized Diluted E P S
----
Rent Expense Supplemental
----
Total Expenses
$ 95.03M$ 88.13M$ -89.77M$ 81.77M
Net Income From Continuing And Discontinued Operation
$ -19.34M$ -3.99M$ 8.62M$ 7.24M
Normalized Income
$ -3.44M$ 2.03M$ 8.25M$ 7.19M
Interest Expense
---$ 312.00K
EBIT
$ -21.19M$ -203.00K$ 8.06M$ 7.67M
EBITDA
$ -19.41M$ 1.60M$ 9.49M$ 9.07M
Currency in USD

Irwin Naturals Inc Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis